The Endocannabinoid System as a Therapeutic Target in Glaucoma

Glaucoma is an irreversible blinding eye disease which produces progressive retinal ganglion cell (RGC) loss. Intraocular pressure (IOP) is currently the only modifiable risk factor, and lowering IOP results in reduced risk of progression of the disorder. The endocannabinoid system (ECS) has attract...

Description complète

Détails bibliographiques

Publié dans:	Neural plasticity. - 1998. - 2016(2016) vom: 15., Seite 9364091
Auteur principal:	Cairns, Elizabeth A (Auteur)
Autres auteurs:	Baldridge, William H, Kelly, Melanie E M
Format:	Article en ligne
Langue:	English
Publié:	2016
Accès à la collection:	Neural plasticity
Sujets:	Journal Article Research Support, Non-U.S. Gov't Review Cannabinoid Receptor Agonists Cannabinoids Endocannabinoids Neuroprotective Agents Receptors, Cannabinoid